Atropine and Pralidoxime Chloride, 'Duodote Kit"

The Department of Health and Human Services Office of the Assistant Secretary for Administration is seeking to procure Atropine and Pralidoxime Chloride autoinjectors, commonly known as Duodote Kits (NDC# 11704-0620-01). This pharmaceutical procurement falls under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Drugs and Biologicals). The pre-solicitation notice was posted on November 20, 2025, with a deadline for submissions set for December 1, 2025, providing potential vendors with approximately 11 days to prepare their responses. While the notice does not specify detailed evaluation criteria or specific contract requirements in the provided documentation, interested vendors should note that this is a civilian procurement with no set-aside designations applied. Contractors should monitor the federal opportunity system closely for the full solicitation release, which will contain comprehensive details regarding technical specifications, compliance requirements, and evaluation methodologies.

The procurement involves a specific quantity of 171 boxes of Duodote autoinjectors, with each box containing 30 units, representing a total of 5,130 individual autoinjectors. No set-aside designation has been applied to this opportunity, meaning all eligible vendors regardless of business classification may compete. The notice does not identify any incumbent contractors or provide an explicit budget range, though interested parties can reference the specific NDC number and quantity to develop cost estimates for their proposals. Vendors with experience in pharmaceutical manufacturing and distribution, particularly those qualified to supply emergency medical autoinjectors, should prioritize this opportunity given the specialized nature of the product and the narrow submission window. The relatively short timeframe between posting and due date suggests this may be an urgent procurement need for the federal agency.